A carregar...

Febuxostat in the management of hyperuricemia and chronic gout: a review

Febuxostat is a novel, potent, non-purine selective xanthine oxidase inhibitor, which in clinical trials demonstrated superior ability to lower and maintain serum urate levels below 6 mg/dL compared with conventionally used doses of allopurinol. Febuxostat was well tolerated in long term treatment i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hu, Miao, Tomlinson, Brian
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2643102/
https://ncbi.nlm.nih.gov/pubmed/19337428
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!